Private equity firms now hold 33,575 portfolio companies they cannot sell, according to a New York Times investigation published Monday. The figure represents a structural mismatch between entry valuations and exit requirements, even as July private equity deal value reached $43.31 billion in a second consecutive month of increases. Brookfield Asset Management and Warburg Pincus led the month's activity, but the volume tells only half the story.
The exit lag reflects purchase prices paid during the 2020-2022 zero-rate environment. Firms bought companies at 12x to 15x EBITDA multiples when their limited partners expected 2.5x to 3.0x cash-on-cash returns within five to seven years. Current buyers, operating with 8 percent cost of debt instead of 3 percent, will pay 9x to 11x for the same assets. The math does not close. PE firms face a choice between selling at losses that trigger clawback provisions or extending hold periods and hoping for EBITDA growth that justifies original entry prices. Most are choosing the latter.
This creates three problems for allocators. First, distributions dry up. Limited partners who expected capital back in 2024 and 2025 now see extension notices pushing exit timelines to 2027 and beyond. That delays their ability to recycle capital into new vintage funds, compressing IRRs across the portfolio. Second, management fees continue. LPs pay 1.5 percent to 2.0 percent annually on committed capital even as portfolio companies age past their value-creation windows. Third, the overhang makes price discovery unreliable. When Brookfield pays $4.7 billion for a sports asset—like the recent Lakers transaction valued at $12.5 billion enterprise value—the multiple looks reasonable only because comparable sales are scarce. PE firms holding similar assets cannot use that transaction as a benchmark because their entry basis sits 30 percent higher.
The secondary market offers one release valve, but at a cost. Secondaries volume reached $47 billion in the first half of 2024, up 18 percent year-over-year, according to Jefferies data. Buyers in that market demand 15 percent to 25 percent discounts to net asset value, which forces selling GPs to either accept the haircut or face LP revolt. Some firms are choosing continuation vehicles, moving unsold companies into new funds and offering LPs a choice: roll your stake or sell at a discount. That structure lets GPs reset the clock and charge a new round of fees, but it also reveals the original fund thesis failed.
Operators and allocators should watch three developments over the next six months. First, whether the Federal Reserve cuts rates in September, which would narrow the valuation gap by 1x to 2x EBITDA for leverage-dependent buyers. Second, how many PE firms launch continuation vehicles in Q4 2024—anything above 40 launches signals the exit problem is accelerating. Third, whether LPs start rejecting management fee waivers in side letters, which would force GPs to absorb extension costs themselves.
The Lakers sale closed at a 26x revenue multiple because scarcity creates its own math. For the other 33,574 companies, scarcity means waiting.